SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2-independent mechanism

Shen, Shu; Zhang, Jingyuan; Fang, Yaohui; Lu, Sihong; Wu, Jun; Zheng, Xin; Deng, Fei

Evidence suggests that platelets may directly interact with SARS-CoV-2, raising the concern whether ACE2 receptor plays a role in this interaction. The current study showed that SARS-CoV-2 interacts with both platelets and megakaryocytes despite the limited efficiency. Abundance of the conventional receptor ACE2 and alternative receptors or co-factors for SARS-CoV-2 entry was characterized in platelets from COVID-19 patients and healthy persons as well as human megakaryocytes based on laboratory tests or previously reported RNA-seq data. The results suggest that SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2-independent mechanism and may regulate alternative receptor expression associated with COVID-19 coagulation dysfunction. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13045-021-01082-6.